TD Asset Management Inc

Position in APGE — Apogee Therapeutics, Inc.

CIK 1056053 Toronto, A6

Position in APGE

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$2,717,514

-$12,836,428 QoQ

Shares Held

20,474

-88.9% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#145

of 285 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. APGE ranks #66 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,717,514	20,474	-88.9%	Shares	Sole	2026-08-04
2026-03-31	$15,553,942	184,792	+42.9%	Shares	Sole	2026-05-11
2025-12-31	$9,758,809	129,290	+55.3%	Shares	Sole	2026-02-10
2025-09-30	$3,307,125	83,240	-12.0%	Shares	Sole	2025-11-10
2025-06-30	$4,107,956	94,588	-6.7%	Shares	Sole	2025-07-28
2025-03-31	$3,787,855	101,388	-19.8%	Shares	Sole	2025-05-07
2024-12-31	$5,728,003	126,446	+35.3%	Shares	Sole	2025-02-11
2024-09-30	$5,489,018	93,446	-1.6%	Shares	Sole	2024-11-01
2024-06-30	$3,738,486	95,006	-35.9%	Shares	Sole	2024-08-02
2024-03-31	$9,848,288	148,206	+47.0%	Shares	Sole	2024-05-08
2023-12-31	$2,817,637	100,846	+217.2%	Shares	Sole	2024-02-12
2023-09-30	$677,212	31,794	—	Shares	Sole	2023-10-27
No filing history on record for this holder in this stock.